71.   Cancer patients often receive several drugs at a time, including anti-nausea and other medications.

72.   Clinical trials showed that the serious side effects occurred when patients were receiving higher dose.

73.   Doctors would also have to talk to the patient about preparing a living will, which could dictate that a patient not receive life support drugs.

74.   Doctors are also often reluctant to prescribe antidepressant medication for fear it will interact badly with painkillers or other medication the patient is receiving.

75.   Doctors said some of the suicides might have been prevented if the patients had received appropriate treatment for depression.

76.   Doctors said that when they could not use viral load to direct treatment, patients were not receiving optimal care.

77.   Dr. Judson Black, an endocrinologist now treating one of them, said his patient apparently received capsules that contained an excessive dose of the medication.

78.   During the first phase, patients receive either the drug or a placebo.

79.   Each patient received an intravenous dose of either nalbuphine, marketed under the trade name Nubain, or butorphanol, marketed as Stadol.

80.   Earlier, Silverstone became known for developing a technique that allowed doctors to determine how much radiation a patient was receiving.